Skip to content
2000
  • ISSN: 1568-0118
  • E-ISSN: 1875-5968

Abstract

CDK2 is an attractive target for the design of new therapeutic antitumor agent. Numerous CDK2 inhibitors have been discovered and their crystallographic structures either in complex with CDK2 or CDK2/Cyclin A have been published. This review aims to summarize the publicly available structural characterization of CDK2/(Cyclin A) - ligand complexes and to highlight the similarities among the binding modes of structurally diverse inhibitors.

Loading

Article metrics loading...

/content/journals/cmcaca/10.2174/1568011054866928
2005-09-01
2025-09-27
Loading full text...

Full text loading...

/content/journals/cmcaca/10.2174/1568011054866928
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test